MENOPAUSE SOCIETY CERTIFIED
PRACTITIONER (MSCP) EXAM| NAMS
MENOPAUSE EXAM BANK REAL EXAM
CURRENTLY TESTING | EXPERT VERIFIED
FOR GUARANTEED PASS 2026.
1. What is the average age of natural menopause?
A. 40–42 years
B. 45–55 years
C. 50–60 years
D. 60–65 years
Correct Answer: B
Rationale: Natural menopause typically occurs between 45–55 years, with the
average around 51.
2. The hallmark of menopause is:
A. Hot flashes
B. Amenorrhea for 12 months
C. Vaginal dryness
D. Decreased bone density
Correct Answer: B
Rationale: Menopause is defined as 12 consecutive months of amenorrhea without
other pathological causes.
3. Perimenopause refers to:
A. The first year after menopause
B. The transition phase before menopause
,C. Any time before age 40
D. Postmenopause
Correct Answer: B
Rationale: Perimenopause is the menopausal transition characterized by
menstrual irregularity and hormonal fluctuations.
4. Common vasomotor symptoms include:
A. Hot flashes and night sweats
B. Vaginal dryness
C. Urinary incontinence
D. Weight gain
Correct Answer: A
Rationale: Vasomotor symptoms are directly related to thermoregulatory
dysfunction caused by estrogen withdrawal.
5. Which hormone level typically declines first during menopause?
A. FSH
B. LH
C. Estradiol
D. Progesterone
Correct Answer: D
Rationale: Progesterone declines early due to anovulatory cycles, while estrogen
declines more gradually.
6. Which lab test is most indicative of menopausal status?
A. Serum estradiol
B. FSH
C. LH
D. Progesterone
,Correct Answer: B
Rationale: Elevated FSH (>30–40 mIU/mL) in the presence of amenorrhea is a
key indicator of menopause.
7. Early menopause occurs before age:
A. 40
B. 45
C. 50
D. 55
Correct Answer: A
Rationale: Menopause before age 40 is considered premature or early and may
require evaluation for underlying causes.
8. The most effective treatment for severe vasomotor symptoms is:
A. Gabapentin
B. Estrogen therapy
C. SSRIs
D. Phytoestrogens
Correct Answer: B
Rationale: Systemic estrogen therapy is the gold standard for relieving severe hot
flashes.
9. Non-hormonal options for hot flashes include:
A. Clonidine
B. SSRIs or SNRIs
C. Gabapentin
D. All of the above
, Correct Answer: D
Rationale: Non-hormonal pharmacologic therapies can be effective for women
who cannot take estrogen.
10. The primary risk of systemic estrogen therapy without a uterus is:
A. Endometrial hyperplasia
B. Breast cancer
C. Cardiovascular disease
D. Osteoporosis
Correct Answer: B
Rationale: Without a uterus, unopposed estrogen does not increase endometrial
cancer risk; the main concern is breast cancer.
11. In women with a uterus, estrogen therapy should be combined with:
A. Progesterone
B. Testosterone
C. Vitamin D
D. Calcium
Correct Answer: A
Rationale: Adding progesterone protects against endometrial hyperplasia and
cancer.
12. Local vaginal estrogen is preferred for:
A. Hot flashes
B. Osteoporosis
C. Vaginal atrophy and dryness
D. Cardiovascular protection
PRACTITIONER (MSCP) EXAM| NAMS
MENOPAUSE EXAM BANK REAL EXAM
CURRENTLY TESTING | EXPERT VERIFIED
FOR GUARANTEED PASS 2026.
1. What is the average age of natural menopause?
A. 40–42 years
B. 45–55 years
C. 50–60 years
D. 60–65 years
Correct Answer: B
Rationale: Natural menopause typically occurs between 45–55 years, with the
average around 51.
2. The hallmark of menopause is:
A. Hot flashes
B. Amenorrhea for 12 months
C. Vaginal dryness
D. Decreased bone density
Correct Answer: B
Rationale: Menopause is defined as 12 consecutive months of amenorrhea without
other pathological causes.
3. Perimenopause refers to:
A. The first year after menopause
B. The transition phase before menopause
,C. Any time before age 40
D. Postmenopause
Correct Answer: B
Rationale: Perimenopause is the menopausal transition characterized by
menstrual irregularity and hormonal fluctuations.
4. Common vasomotor symptoms include:
A. Hot flashes and night sweats
B. Vaginal dryness
C. Urinary incontinence
D. Weight gain
Correct Answer: A
Rationale: Vasomotor symptoms are directly related to thermoregulatory
dysfunction caused by estrogen withdrawal.
5. Which hormone level typically declines first during menopause?
A. FSH
B. LH
C. Estradiol
D. Progesterone
Correct Answer: D
Rationale: Progesterone declines early due to anovulatory cycles, while estrogen
declines more gradually.
6. Which lab test is most indicative of menopausal status?
A. Serum estradiol
B. FSH
C. LH
D. Progesterone
,Correct Answer: B
Rationale: Elevated FSH (>30–40 mIU/mL) in the presence of amenorrhea is a
key indicator of menopause.
7. Early menopause occurs before age:
A. 40
B. 45
C. 50
D. 55
Correct Answer: A
Rationale: Menopause before age 40 is considered premature or early and may
require evaluation for underlying causes.
8. The most effective treatment for severe vasomotor symptoms is:
A. Gabapentin
B. Estrogen therapy
C. SSRIs
D. Phytoestrogens
Correct Answer: B
Rationale: Systemic estrogen therapy is the gold standard for relieving severe hot
flashes.
9. Non-hormonal options for hot flashes include:
A. Clonidine
B. SSRIs or SNRIs
C. Gabapentin
D. All of the above
, Correct Answer: D
Rationale: Non-hormonal pharmacologic therapies can be effective for women
who cannot take estrogen.
10. The primary risk of systemic estrogen therapy without a uterus is:
A. Endometrial hyperplasia
B. Breast cancer
C. Cardiovascular disease
D. Osteoporosis
Correct Answer: B
Rationale: Without a uterus, unopposed estrogen does not increase endometrial
cancer risk; the main concern is breast cancer.
11. In women with a uterus, estrogen therapy should be combined with:
A. Progesterone
B. Testosterone
C. Vitamin D
D. Calcium
Correct Answer: A
Rationale: Adding progesterone protects against endometrial hyperplasia and
cancer.
12. Local vaginal estrogen is preferred for:
A. Hot flashes
B. Osteoporosis
C. Vaginal atrophy and dryness
D. Cardiovascular protection
